Skip to main content
All lobbying filings

UPSTREAM CONSULTING

Lobbying for PRIMUS PHARMACEUTICAL · Pharmaceutical drug manufacturing

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Virginia

Official filing document

 Conviction disclosures 1

A registrant must disclose criminal convictions of the lobbyists it lists, under the Honest Leadership and Open Government Act. This is the filer's own wording.

  • MCCLAIN C HADDOW 1987
    9/15/1987, U.S. District Court, 18 U.S.C. Section 208(a), conflict of interest (2 counts)
 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Protect access of medical foods.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem